Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.

Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J; ADNI investigators.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):168-73. doi: 10.1097/WAD.0b013e318260a79a.

2.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

3.

Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.

Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ.

J Alzheimers Dis. 2015;48(1):197-204. doi: 10.3233/JAD-150063.

PMID:
26401940
4.

Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.

Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H.

Neurology. 2008 Dec 9;71(24):1986-92. doi: 10.1212/01.wnl.0000336925.79704.9f.

5.

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC.

Neurology. 2005 Oct 25;65(8):1227-31.

6.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
7.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F.

Neurology. 2009 Mar 17;72(11):999-1007. doi: 10.1212/01.wnl.0000344568.09360.31.

8.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
9.

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.

Neurology. 2007 Oct 9;69(15):1491-7.

PMID:
17923611
10.

Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.

Khan W, Westman E, Jones N, Wahlund LO, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Muehlboeck JS, Simmons A; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative.

Brain Topogr. 2015 Sep;28(5):746-59. doi: 10.1007/s10548-014-0415-1. Epub 2014 Nov 5.

11.

Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?

Boutet C, Chupin M, Colliot O, Sarazin M, Mutlu G, Drier A, Pellot A, Dormont D, Lehéricy S; Alzheimer’s Disease Neuroimaging Initiative.

Neuroradiology. 2012 Dec;54(12):1321-30. doi: 10.1007/s00234-012-1058-0. Epub 2012 Jul 11.

PMID:
22782577
12.

Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.

Wang PN, Liu HC, Lirng JF, Lin KN, Wu ZA.

Psychiatry Res. 2009 Mar 31;171(3):221-31. doi: 10.1016/j.pscychresns.2008.05.002. Epub 2009 Feb 13.

PMID:
19217759
13.

Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.

Hänggi J, Streffer J, Jäncke L, Hock C.

J Alzheimers Dis. 2011;26(4):719-34. doi: 10.3233/JAD-2011-101260.

PMID:
21709375
14.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

15.

High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.

Kovacevic S, Rafii MS, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):139-45. doi: 10.1097/WAD.0b013e318192e745.

16.

Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.

Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou YY, Toga AW, Thompson PM.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):17-27. doi: 10.1097/WAD.0b013e3182163b62.

17.

Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease.

Enache D, Cavallin L, Lindberg O, Farahmand B, Kramberger MG, Westman E, Jelic V, Eriksdotter M, Ballard C, Winblad B, Wahlund LO, Aarsland D.

J Geriatr Psychiatry Neurol. 2015 Mar;28(1):40-8. doi: 10.1177/0891988714541873. Epub 2014 Jul 30.

PMID:
25080472
18.

Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Mah L, Binns MA, Steffens DC; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2015 May;23(5):466-76. doi: 10.1016/j.jagp.2014.10.005. Epub 2014 Oct 29.

19.

Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.

Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.

J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.

PMID:
25322924
20.

Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.

Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 May 15;92:169-81. doi: 10.1016/j.neuroimage.2014.01.058. Epub 2014 Feb 9.

PMID:
24521851

Supplemental Content

Support Center